as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

This study found that clients of safer opioid supply (SOS) programs in Toronto experienced fewer overdoses and reduced use of unregulated drugs. Participants also reported improved social outcomes, suggesting SOS programs may help mitigate overdose risks.

as part of Policy Impact Unit

This report analyzes the impact of the Cannabis Act on equity seeking groups and draws on best practices to develop a roadmap for cannabis equity in Canada, with the aim of informing the federal legislated review of the Cannabis Act.

as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

This publication examines the implementation challenges faced by Canada's safer supply pilot programs, which provide pharmaceutical alternatives to individuals accessing the unregulated drug supply, highlighting organizational, structural, and procedural barriers encountered during their initial phases.

as part of Systematic Reviews on Drug Policy

This study systematically reviews factors associated with the increasing use of methamphetamine among people who use opioids, highlighting demographic, socioeconomic, and behavioral risks, and emphasizing the need for expanded harm reduction and treatment interventions.

as part of Systematic Reviews on Drug Policy

This study reviews the prevalence and experiences of abortion among female sex workers (FSWs), finding high rates of induced and self-managed abortions, particularly in countries where elective abortion is illegal, and emphasizing the need for improved access to contraception and safe abortion care.

as part of Safer Opioid Supply Programs Evaluation in Toronto, Ontario

A study in British Columbia found that rural TiOAT programs face barriers like transportation and strict dosing schedules, though participants valued the supportive, stigma-free clinic environments. Interruptions during hospital stays or incarceration highlighted gaps in continuity of care.

as part of Systematic Reviews on Drug Policy

This qualitative narrative synthesis explores pathways linking socioeconomic marginalization (SEM) to overdose among people who use drugs.

as part of T-DOT (Toronto Disparities, Overdose and Treatment), formerly OiSIS

Those requiring help injecting are at an elevated risk of injection-related injury and blood-borne infections and are thus a priority group for harm reduction programs. As supervised consumption services (SCS) are scaled-up across Canada, information on those who require help injecting is necessary to inform equitable service uptake. We characterised the sociodemographic, structural and drug use correlates of needing help injecting among a cohort of people who inject drugs in Toronto, Canada.

as part of T-DOT (Toronto Disparities, Overdose and Treatment), formerly OiSIS

Studies of people who inject drugs (PWID) commonly use questionnaires to determine whether participants are currently, or have recently been, on opioid agonist treatment for opioid use disorder. However, these previously unvalidated self-reported treatment measures may be susceptible to inaccurate reporting.

as part of Piloting and Evaluating Drug Checking Services in Toronto, Ontario

Drug checking services (DCS) provide information on drug composition to inform consumption practices and monitor unregulated drug markets. We sought to identify correlates of recent informal DCS use (e.g., fentanyl test strips) and willingness to use a formal DCS (co-located within a supervised consumption site and employing laboratory-based analyses) in Toronto, Canada prior to its implementation.